BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Woods CP, Hazlehurst JM, Tomlinson JW. Glucocorticoids and non-alcoholic fatty liver disease. J Steroid Biochem Mol Biol. 2015;154:94-103. [PMID: 26241028 DOI: 10.1016/j.jsbmb.2015.07.020] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 10.6] [Reference Citation Analysis]
Number Citing Articles
1 Mei W, Hao Y, Xie H, Ni Y, Zhao R. Hepatic Inflammatory Response to Exogenous LPS Challenge is Exacerbated in Broilers with Fatty Liver Disease. Animals (Basel) 2020;10:E514. [PMID: 32204385 DOI: 10.3390/ani10030514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Appanna N, Gibson H, Gangitano E, Dempster NJ, Morris K, George S, Arvaniti A, Gathercole LL, Keevil B, Penning TM, Storbeck KH, Tomlinson JW, Nikolaou N. Differential activity and expression of human 5β-reductase (AKR1D1) splice variants. J Mol Endocrinol 2021;66:181-94. [PMID: 33502336 DOI: 10.1530/JME-20-0160] [Reference Citation Analysis]
3 Flamini S, Sergeev P, Viana de Barros Z, Mello T, Biagioli M, Paglialunga M, Fiorucci C, Prikazchikova T, Pagano S, Gagliardi A, Riccardi C, Zatsepin T, Migliorati G, Bereshchenko O, Bruscoli S. Glucocorticoid-induced leucine zipper regulates liver fibrosis by suppressing CCL2-mediated leukocyte recruitment. Cell Death Dis 2021;12:421. [PMID: 33927191 DOI: 10.1038/s41419-021-03704-w] [Reference Citation Analysis]
4 Barbouche R, Gaigé S, Airault C, Poirot K, Dallaporta M, Troadec JD, Abysique A. The food contaminant deoxynivalenol provokes metabolic impairments resulting in non-alcoholic fatty liver (NAFL) in mice. Sci Rep 2020;10:12072. [PMID: 32694515 DOI: 10.1038/s41598-020-68712-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Xiang L, Jiao Y, Qian Y, Li Y, Mao F, Lu Y. Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease. Genes Dis 2022;9:201-15. [PMID: 35005119 DOI: 10.1016/j.gendis.2021.02.008] [Reference Citation Analysis]
6 Chen L, Fan Z, Sun X, Qiu W, Chen Y, Zhou J, Lv G. Mendelian Randomization Rules Out Causation Between Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease. Front Pharmacol 2022;13:891410. [DOI: 10.3389/fphar.2022.891410] [Reference Citation Analysis]
7 Eshraghian A, Nikeghbalian S, Kazemi K, Shamsaeefar A, Geramizadeh B, Malek-Hosseini SA. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis. HPB (Oxford) 2020;22:521-8. [PMID: 31431413 DOI: 10.1016/j.hpb.2019.07.015] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Naour S, Espinoza BM, Aedo JE, Zuloaga R, Maldonado J, Bastias-Molina M, Silva H, Meneses C, Gallardo-Escarate C, Molina A, Valdés JA. Transcriptomic analysis of the hepatic response to stress in the red cusk-eel (Genypterus chilensis): Insights into lipid metabolism, oxidative stress and liver steatosis. PLoS One 2017;12:e0176447. [PMID: 28448552 DOI: 10.1371/journal.pone.0176447] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
9 Negi CK, Babica P, Bajard L, Bienertova-Vasku J, Tarantino G. Insights into the molecular targets and emerging pharmacotherapeutic interventions for nonalcoholic fatty liver disease. Metabolism 2021;126:154925. [PMID: 34740573 DOI: 10.1016/j.metabol.2021.154925] [Reference Citation Analysis]
10 Pasieka AM, Rafacho A. Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence. Metabolites 2016;6:E24. [PMID: 27527232 DOI: 10.3390/metabo6030024] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 6.5] [Reference Citation Analysis]
11 Doulberis M, Kotronis G, Gialamprinou D, Kountouras J, Katsinelos P. Non-alcoholic fatty liver disease: An update with special focus on the role of gut microbiota. Metabolism 2017;71:182-97. [DOI: 10.1016/j.metabol.2017.03.013] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 13.4] [Reference Citation Analysis]
12 Kinlein SA, Shahanoor Z, Romeo RD, Karatsoreos IN. Chronic Corticosterone Treatment During Adolescence Has Significant Effects on Metabolism and Skeletal Development in Male C57BL6/N Mice. Endocrinology 2017;158:2239-54. [PMID: 28510653 DOI: 10.1210/en.2017-00208] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
13 Buurstede JC, Paul SN, De Bosscher K, Meijer OC, Kroon J. Hepatic glucocorticoid-induced transcriptional regulation is androgen-dependent after chronic but not acute glucocorticoid exposure. FASEB J 2022;36:e22251. [PMID: 35262955 DOI: 10.1096/fj.202101313R] [Reference Citation Analysis]
14 Deng Z, Lu D. Letter by Lu et al regarding article "Antenatal corticosteroid therapy: Historical and scientific basis to improve preterm birth management". Eur J Obstet Gynecol Reprod Biol 2021:S0301-2115(21)00510-8. [PMID: 34732306 DOI: 10.1016/j.ejogrb.2021.10.021] [Reference Citation Analysis]
15 Shittu ST, Lasisi TJ, Shittu SA, Adeyemi A, Adeoye TJ, Alada AA. Ocimum gratissimum enhances insulin sensitivity in male Wistar rats with dexamethasone-induced insulin resistance. J Diabetes Metab Disord 2021;20:1257-67. [PMID: 34900777 DOI: 10.1007/s40200-021-00850-y] [Reference Citation Analysis]
16 Gaggini M, Carli F, Gastaldelli A. The color of fat and its central role in the development and progression of metabolic diseases. Horm Mol Biol Clin Investig 2017;31:/j/hmbci. [PMID: 28942436 DOI: 10.1515/hmbci-2017-0060] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
17 Wan S, Zhang L, Quan Y, Wei K. Resveratrol-loaded PLGA nanoparticles: enhanced stability, solubility and bioactivity of resveratrol for non-alcoholic fatty liver disease therapy. R Soc Open Sci 2018;5:181457. [PMID: 30564426 DOI: 10.1098/rsos.181457] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 9.8] [Reference Citation Analysis]
18 Brachs S, Winkel AF, Tang H, Birkenfeld AL, Brunner B, Jahn-Hofmann K, Margerie D, Ruetten H, Schmoll D, Spranger J. Inhibition of citrate cotransporter Slc13a5/mINDY by RNAi improves hepatic insulin sensitivity and prevents diet-induced non-alcoholic fatty liver disease in mice. Mol Metab 2016;5:1072-82. [PMID: 27818933 DOI: 10.1016/j.molmet.2016.08.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
19 Shukla PK, Meena AS, Pierre JF, Rao R. Central role of intestinal epithelial glucocorticoid receptor in alcohol- and corticosterone-induced gut permeability and systemic response. FASEB J 2022;36:e22061. [PMID: 34861075 DOI: 10.1096/fj.202101424R] [Reference Citation Analysis]
20 Hu S, Luo L, Bian X, Liu RH, Zhao S, Chen Y, Sun K, Jiang J, Liu Z, Zeng L. Pu-erh Tea Restored Circadian Rhythm Disruption by Regulating Tryptophan Metabolism. J Agric Food Chem 2022. [PMID: 35475616 DOI: 10.1021/acs.jafc.2c01883] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Philips CA, Kakkar K, Joseph M, Yerol PK, Ahamed R, Rajesh S, Augustine P. Critically Ill COVID-19 Patient with Chronic Liver Disease - Insights into a Comprehensive Liver Intensive Care. J Clin Transl Hepatol 2021;9:576-86. [PMID: 34447688 DOI: 10.14218/JCTH.2020.00110] [Reference Citation Analysis]
22 Ghaddar B, Diotel N. Zebrafish: A New Promise to Study the Impact of Metabolic Disorders on the Brain. Int J Mol Sci 2022;23:5372. [PMID: 35628176 DOI: 10.3390/ijms23105372] [Reference Citation Analysis]
23 Cheng F, Ma C, Wang X, Zhai C, Wang G, Xu X, Mu J, Li C, Wang Z, Zhang X, Yue W, Du X, Lian Y, Zhu W, Yin X, Wei Z, Song W, Wang Q. Effect of traditional Chinese medicine formula Sinisan on chronic restraint stress-induced nonalcoholic fatty liver disease: a rat study. BMC Complement Altern Med 2017;17:203. [PMID: 28388904 DOI: 10.1186/s12906-017-1707-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 4.4] [Reference Citation Analysis]
24 Freese J, Klement RJ, Ruiz-Núñez B, Schwarz S, Lötzerich H. The sedentary (r)evolution: Have we lost our metabolic flexibility? F1000Res 2017;6:1787. [PMID: 29225776 DOI: 10.12688/f1000research.12724.2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 2.6] [Reference Citation Analysis]
25 Chalasani S, Mathur K, Shammas N, Orman E, Vuppalanchi R, Lammert C. Hepatic steatosis is highly prevalent but is not correlated with stiffness in autoimmune hepatitis. Medicine (Baltimore) 2020;99:e22805. [PMID: 33080756 DOI: 10.1097/MD.0000000000022805] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Balsevich G, Petrie GN, Hill MN. Endocannabinoids: Effectors of glucocorticoid signaling. Front Neuroendocrinol 2017;47:86-108. [PMID: 28739508 DOI: 10.1016/j.yfrne.2017.07.005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
27 Allard J, Le Guillou D, Begriche K, Fromenty B. Drug-induced liver injury in obesity and nonalcoholic fatty liver disease. Adv Pharmacol 2019;85:75-107. [PMID: 31307592 DOI: 10.1016/bs.apha.2019.01.003] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
28 Zingariello M, Bardelli C, Sancillo L, Ciaffoni F, Genova ML, Girelli G, Migliaccio AR. Dexamethasone Predisposes Human Erythroblasts Toward Impaired Lipid Metabolism and Renders Their ex vivo Expansion Highly Dependent on Plasma Lipoproteins. Front Physiol 2019;10:281. [PMID: 31019464 DOI: 10.3389/fphys.2019.00281] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
29 Kim M, Lee HA, Cho HM, Kang SH, Lee E, Kim IK. Histone deacetylase inhibition attenuates hepatic steatosis in rats with experimental Cushing's syndrome. Korean J Physiol Pharmacol 2018;22:23-33. [PMID: 29302209 DOI: 10.4196/kjpp.2018.22.1.23] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
30 Adar T, Ya'acov AB, Shabat Y, Mizrahi M, Zolotarov L, Lichtenstein Y, Ilan Y. Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent. BMC Gastroenterol 2022;22:169. [PMID: 35392825 DOI: 10.1186/s12876-022-02242-9] [Reference Citation Analysis]
31 Jiang Z, Zhang C, Liu X, Ma X, Bian X, Xiao X, Gao R, Sun Y, Wu W, Zhao P. Dexamethasone inhibits stemness maintenance and enhances chemosensitivity of hepatocellular carcinoma stem cells by inducing deSUMOylation of HIF‑1α and Oct4. Int J Oncol 2020;57:780-90. [PMID: 32705164 DOI: 10.3892/ijo.2020.5097] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 Tao Y, Xu S, Wang J, Xu L, Zhang C, Chen K, Lian Z, Zhou J, Xie H, Zheng S, Xu X. Delivery of microRNA-33 Antagomirs by Mesoporous Silica Nanoparticles to Ameliorate Lipid Metabolic Disorders. Front Pharmacol 2020;11:921. [PMID: 32848718 DOI: 10.3389/fphar.2020.00921] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
33 Werumeus Buning J, Kootstra-Ros JE, Brummelman P, van den Berg G, van der Klauw M, Wolffenbuttel BH, van Beek AP, Dullaart RP. Higher hydrocortisone dose increases bilirubin in hypopituitary patients- results from an RCT. Eur J Clin Invest 2016;46:475-80. [PMID: 26999644 DOI: 10.1111/eci.12624] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hong T, Chen Y, Li X, Lu Y. The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD. Oxid Med Cell Longev 2021;2021:6889533. [PMID: 34745420 DOI: 10.1155/2021/6889533] [Reference Citation Analysis]
35 Lee MCM, Kachura JJ, Vlachou PA, Dzulynsky R, Di Tomaso A, Samawi H, Baxter N, Brezden-Masley C. Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer. Curr Oncol 2021;28:3030-40. [PMID: 34436031 DOI: 10.3390/curroncol28040265] [Reference Citation Analysis]
36 Liu Y, Wu X, Mi Y, Zhang B, Gu S, Liu G, Li X. PLGA nanoparticles for the oral delivery of nuciferine: preparation, physicochemical characterization and in vitro/in vivo studies. Drug Deliv 2017;24:443-51. [PMID: 28165858 DOI: 10.1080/10717544.2016.1261381] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
37 Báez-Ruiz A, Guerrero-Vargas NN, Cázarez-Márquez F, Sabath E, Basualdo MDC, Salgado-Delgado R, Escobar C, Buijs RM. Food in synchrony with melatonin and corticosterone relieves constant light disturbed metabolism. J Endocrinol 2017;235:167-78. [PMID: 28851750 DOI: 10.1530/JOE-17-0370] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
38 Zhang Y, Li JX, Zhang Y, Wang YL. Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis . World J Clin Cases 2021; 9(23): 6654-6662 [PMID: 34447812 DOI: 10.12998/wjcc.v9.i23.6654] [Reference Citation Analysis]
39 Moraes AC, Prado EJ, Foz EP, Barbuio R, Faria VP, Belo MA. Esteatose hepática altera acúmulo celular em tilápias do Nilo durante aerocistite infecciosa. Pesq Vet Bras 2018;38:1570-6. [DOI: 10.1590/1678-5150-pvb-5533] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Shimizu H, Shimizu T, Takahashi D, Asano T, Arai R, Takakuwa Y, Iwasaki N. Corticosteroid dose increase is a risk factor for nonalcoholic fatty liver disease and contralateral osteonecrosis of the femoral head: a case report. BMC Musculoskelet Disord 2019;20:88. [PMID: 30782153 DOI: 10.1186/s12891-019-2468-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
41 Kim JH, Yoon HK, Lee HC, Park HP, Park CK, Dho YS, Hwang JW. Preoperative 5-aminolevulinic acid administration for brain tumor surgery is associated with an increase in postoperative liver enzymes: a retrospective cohort study. Acta Neurochir (Wien) 2019;161:2289-98. [PMID: 31473825 DOI: 10.1007/s00701-019-04053-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
42 Vojnović Milutinović D, Teofilović A, Veličković N, Brkljačić J, Jelača S, Djordjevic A, Macut D. Glucocorticoid signaling and lipid metabolism disturbances in the liver of rats treated with 5α-dihydrotestosterone in an animal model of polycystic ovary syndrome. Endocrine 2021;72:562-72. [PMID: 33449293 DOI: 10.1007/s12020-020-02600-1] [Reference Citation Analysis]
43 Massart J, Begriche K, Corlu A, Fromenty B. Xenobiotic-Induced Aggravation of Metabolic-Associated Fatty Liver Disease. IJMS 2022;23:1062. [DOI: 10.3390/ijms23031062] [Reference Citation Analysis]
44 Rahimi L, Rajpal A, Ismail-Beigi F. Glucocorticoid-Induced Fatty Liver Disease. Diabetes Metab Syndr Obes 2020;13:1133-45. [PMID: 32368109 DOI: 10.2147/DMSO.S247379] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
45 Marjot T, Ray DW, Williams FR, Tomlinson JW, Armstrong MJ. Sleep and liver disease: a bidirectional relationship. Lancet Gastroenterol Hepatol 2021:S2468-1253(21)00169-2. [PMID: 34273289 DOI: 10.1016/S2468-1253(21)00169-2] [Reference Citation Analysis]
46 Dang F, Wu R, Wang P, Wu Y, Azam MS, Xu Q, Chen Y, Liu Y. Fasting and Feeding Signals Control the Oscillatory Expression of Angptl8 to Modulate Lipid Metabolism. Sci Rep 2016;6:36926. [PMID: 27845381 DOI: 10.1038/srep36926] [Cited by in Crossref: 29] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
47 Lai S, Lin C, Liao K. Synergistic effect of oral corticosteroids use on risk of hepatocellular carcinoma in high risk populations. European Journal of Internal Medicine 2018;52:73-7. [DOI: 10.1016/j.ejim.2018.03.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ji Y, Elkin K, Yip J, Guan L, Han W, Ding Y. From circadian clocks to non-alcoholic fatty liver disease. Expert Review of Gastroenterology & Hepatology 2019;13:1107-12. [DOI: 10.1080/17474124.2019.1684899] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
49 Jarmakiewicz-czaja S, Sokal A, Pardak P, Filip R, Granito A. Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease. Canadian Journal of Gastroenterology and Hepatology 2022;2022:1-13. [DOI: 10.1155/2022/4344905] [Reference Citation Analysis]
50 Beaupere C, Liboz A, Fève B, Blondeau B, Guillemain G. Molecular Mechanisms of Glucocorticoid-Induced Insulin Resistance. Int J Mol Sci 2021;22:E623. [PMID: 33435513 DOI: 10.3390/ijms22020623] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
51 Gabrielli M, Franza L, Esperide A, Gasparrini I, Gasbarrini A, Franceschi F; on behalf of GEMELLI AGAINST COVID 2019. Liver Injury in Patients Hospitalized for COVID-19: Possible Role of Therapy. Vaccines 2022;10:192. [DOI: 10.3390/vaccines10020192] [Reference Citation Analysis]
52 Wen B, Zhang C, Zhou J, Zhang Z, Che Q, Cao H, Bai Y, Guo J, Su Z. Targeted treatment of alcoholic liver disease based on inflammatory signalling pathways. Pharmacol Ther 2021;222:107752. [PMID: 33253739 DOI: 10.1016/j.pharmthera.2020.107752] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
53 Marri UK, Madhusudhan KS. Dual-Energy Computed Tomography in Diffuse Liver Diseases. Journal of Gastrointestinal and Abdominal Radiology. [DOI: 10.1055/s-0042-1742432] [Reference Citation Analysis]
54 Xiao Y, Kim M, Lazar MA. Nuclear receptors and transcriptional regulation in non-alcoholic fatty liver disease. Mol Metab 2021;50:101119. [PMID: 33220489 DOI: 10.1016/j.molmet.2020.101119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
55 Hu Y, Sun Q, Liu J, Jia Y, Cai D, Idriss AA, Omer NA, Zhao R. In ovo injection of betaine alleviates corticosterone-induced fatty liver in chickens through epigenetic modifications. Sci Rep 2017;7:40251. [PMID: 28059170 DOI: 10.1038/srep40251] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 3.4] [Reference Citation Analysis]
56 Gebreselassie A, Aduli F, Howell CD. Rheumatologic Diseases and the Liver. Clinics in Liver Disease 2019;23:247-61. [DOI: 10.1016/j.cld.2018.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
57 Sartini A, Gitto S, Villa E. Does Metabolic Syndrome and Not the Inflammatory Load Predict Nonalcoholic Fatty Liver Disease Severity in Inflammatory Bowel Disease Patients? Dig Dis Sci 2017;62:2604-6. [DOI: 10.1007/s10620-017-4665-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
58 Gariani K, Jornayvaz FR. Pathophysiology of NASH in endocrine diseases. Endocr Connect 2021;10:R52-65. [PMID: 33449917 DOI: 10.1530/EC-20-0490] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
59 Sztolsztener K, Harasim-Symbor E, Chabowski A, Konstantynowicz-Nowicka K. The influence of dexamethasone on hepatic fatty acids metabolism and transport in human steatotic HepG2 cell line exposed to palmitate. Biochem Biophys Res Commun 2021;585:132-8. [PMID: 34801933 DOI: 10.1016/j.bbrc.2021.11.044] [Reference Citation Analysis]
60 Harasim-Symbor E, Konstantynowicz-Nowicka K, Chabowski A. Additive effects of dexamethasone and palmitate on hepatic lipid accumulation and secretion. J Mol Endocrinol 2016;57:261-73. [PMID: 27707773 DOI: 10.1530/JME-16-0108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
61 Mosili P, Mkhize BC, Ngubane P, Sibiya N, Khathi A. The dysregulation of the hypothalamic-pituitary-adrenal axis in diet-induced prediabetic male Sprague Dawley rats. Nutr Metab (Lond) 2020;17:104. [PMID: 33308255 DOI: 10.1186/s12986-020-00532-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
62 Güven A. Different Potent Glucocorticoids, Different Routes of Exposure but the Same Result: Iatrogenic Cushing’s Syndrome and Adrenal Insufficiency. J Clin Res Pediatr Endocrinol 2020;12:383-92. [PMID: 32431136 DOI: 10.4274/jcrpe.galenos.2020.2019.0220] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Wijarnpreecha K, Thongprayoon C, Panjawatanan P, Ungprasert P. Short sleep duration and risk of nonalcoholic fatty liver disease: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2016;31:1802-1807. [PMID: 27029776 DOI: 10.1111/jgh.13391] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
64 Sharma AK, Shi X, Isales CM, McGee-Lawrence ME. Endogenous Glucocorticoid Signaling in the Regulation of Bone and Marrow Adiposity: Lessons from Metabolism and Cross Talk in Other Tissues. Curr Osteoporos Rep 2019;17:438-45. [PMID: 31749087 DOI: 10.1007/s11914-019-00554-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
65 Shetty A, Hsu JW, Manka PP, Syn WK. Role of the Circadian Clock in the Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. Dig Dis Sci 2018;63:3187-206. [PMID: 30121811 DOI: 10.1007/s10620-018-5242-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 6.3] [Reference Citation Analysis]
66 Vega N, Pinteur C, Buffelan G, Loizon E, Vidal H, Naville D, Le Magueresse-battistoni B. Exposure to pollutants altered glucocorticoid signaling and clock gene expression in female mice. Evidence of tissue- and sex-specificity. Chemosphere 2021;262:127841. [DOI: 10.1016/j.chemosphere.2020.127841] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
67 Mallappa A, Nella AA, Sinaii N, Rao H, Gounden V, Perritt AF, Kumar P, Ling A, Liu CY, Soldin SJ, Merke DP. Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia. Clin Endocrinol (Oxf) 2018;89:399-407. [PMID: 30003563 DOI: 10.1111/cen.13813] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
68 Cataldi M, Citro V, Resnati C, Manco F, Tarantino G. New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants. Adv Ther 2021;38:2094-113. [PMID: 33761100 DOI: 10.1007/s12325-021-01669-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
69 Jacobsen MC, Thrower SL, Ger RB, Leng S, Court LE, Brock KK, Tamm EP, Cressman ENK, Cody DD, Layman RR. Multi-energy computed tomography and material quantification: Current barriers and opportunities for advancement. Med Phys 2020;47:3752-71. [PMID: 32453879 DOI: 10.1002/mp.14241] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Zhang S, Xu Y, Zhang S, Zhao C, Feng D, Feng X. Fluorene-9-bisphenol exposure decreases locomotor activity and induces lipid-metabolism disorders by impairing fatty acid oxidation in zebrafish. Life Sci 2022;294:120379. [PMID: 35134438 DOI: 10.1016/j.lfs.2022.120379] [Reference Citation Analysis]
71 Yang F, Fang B, Pang G, Ren F. Organophosphorus pesticide triazophos: A new endocrine disruptor chemical of hypothalamus-pituitary-adrenal axis. Pesticide Biochemistry and Physiology 2019;159:91-7. [DOI: 10.1016/j.pestbp.2019.05.021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
72 Freese J, Klement RJ, Ruiz-Núñez B, Schwarz S, Lötzerich H. The sedentary (r)evolution: Have we lost our metabolic flexibility? F1000Res 2017;6:1787. [PMID: 29225776 DOI: 10.12688/f1000research.12724.2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
73 Chen TC, Lee RA, Tsai SL, Kanamaluru D, Gray NE, Yiv N, Cheang RT, Tan JH, Lee JY, Fitch MD, Hellerstein MK, Wang JC. An ANGPTL4-ceramide-protein kinase Cζ axis mediates chronic glucocorticoid exposure-induced hepatic steatosis and hypertriglyceridemia in mice. J Biol Chem 2019;294:9213-24. [PMID: 31053639 DOI: 10.1074/jbc.RA118.006259] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
74 Sartini A, Gitto S, Bianchini M, Verga MC, Di Girolamo M, Bertani A, Del Buono M, Schepis F, Lei B, De Maria N, Villa E. Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease. Cell Death Dis. 2018;9:87. [PMID: 29367619 DOI: 10.1038/s41419-017-0124-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
75 Li R, Guo C, Lin X, Chan TF, Su M, Zhang Z, Lai KP. Integrative omics analysis reveals the protective role of vitamin C on perfluorooctanoic acid-induced hepatoxicity. J Adv Res 2022;35:279-94. [PMID: 35024202 DOI: 10.1016/j.jare.2021.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 Chen X, Ma T, Yip R, Perumalswami PV, Branch AD, Lewis S, Crane M, Yankelevitz DF, Henschke CI. Elevated prevalence of moderate-to-severe hepatic steatosis in World Trade Center General Responder Cohort in a program of CT lung screening. Clin Imaging 2020;60:237-43. [PMID: 31945662 DOI: 10.1016/j.clinimag.2019.12.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
77 Quattrocelli M, Zelikovich AS, Salamone IM, Fischer JA, McNally EM. Mechanisms and Clinical Applications of Glucocorticoid Steroids in Muscular Dystrophy. J Neuromuscul Dis 2021;8:39-52. [PMID: 33104035 DOI: 10.3233/JND-200556] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
78 Parker JC, Moraitis AG, Belanoff JK. Biochemical and Radiological Changes in Liver Steatosis Following Mifepristone Treatment in Patients With Hypercortisolism. AACE Clinical Case Reports 2022;8:25-9. [DOI: 10.1016/j.aace.2021.07.001] [Reference Citation Analysis]
79 Shao Q, Wu Y, Ji J, Xu T, Yu Q, Ma C, Liao X, Cheng F, Wang X. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Front Psychiatry 2021;12:711835. [PMID: 34966296 DOI: 10.3389/fpsyt.2021.711835] [Reference Citation Analysis]
80 Trivedi HD, Lopes EW, Glissen Brown J, Dudani S, Lai M, Feuerstein JD, Pierce TT. Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: Systematic Review and Meta-analysis. J Clin Gastroenterol 2022. [PMID: 35648974 DOI: 10.1097/MCG.0000000000001727] [Reference Citation Analysis]
81 Tarantino G, Citro V, Cataldi M. Findings from Studies Are Congruent with Obesity Having a Viral Origin, but What about Obesity-Related NAFLD? Viruses 2021;13:1285. [PMID: 34372491 DOI: 10.3390/v13071285] [Reference Citation Analysis]
82 Hu Y, Sun Q, Zong Y, Liu J, Idriss AA, Omer NA, Zhao R. Prenatal betaine exposure alleviates corticosterone-induced inhibition of CYP27A1 expression in the liver of juvenile chickens associated with its promoter DNA methylation. Gen Comp Endocrinol 2017;246:241-8. [PMID: 28039067 DOI: 10.1016/j.ygcen.2016.12.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
83 Ragucci E, Nguyen D, Lamerson M, Moraitis AG. Effects of Mifepristone on Nonalcoholic Fatty Liver Disease in a Patient with a Cortisol-Secreting Adrenal Adenoma. Case Rep Endocrinol 2017;2017:6161348. [PMID: 29348947 DOI: 10.1155/2017/6161348] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
84 Law MF, Ho R, Law KWT, Cheung CKM. Gastrointestinal and hepatic side effects of potential treatment for COVID-19 and vaccination in patients with chronic liver diseases. World J Hepatol 2021; 13(12): 1850-1874 [DOI: 10.4254/wjh.v13.i12.1850] [Reference Citation Analysis]
85 Nagaraju R, Joshi AKR, Vamadeva SG, Rajini PS. Deregulation of hepatic lipid metabolism associated with insulin resistance in rats subjected to chronic monocrotophos exposure. J Biochem Mol Toxicol 2020;34:e22506. [PMID: 32267039 DOI: 10.1002/jbt.22506] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 Hay RE, Edwards A, Klein M, Hyland L, MacDonald D, Karatsoreos I, Hill MN, Abizaid A. Ghrelin Receptor Signaling Is Not Required for Glucocorticoid-Induced Obesity in Male Mice. Endocrinology 2020;161:bqz023. [PMID: 31748785 DOI: 10.1210/endocr/bqz023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
87 Yang F, Dai Y, Min C, Li X. Neonatal overfeeding induced glucocorticoid overexposure accelerates hepatic lipogenesis in male rats. Nutr Metab (Lond) 2018;15:30. [PMID: 29743929 DOI: 10.1186/s12986-018-0272-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]